Total Funding
35
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Mydecine Innovation Group is an innovative Cannabidiol ("CBD") lifestyle Company.
- Damon Michaels: Chief Operations OfficerPast Role: ebbu, General Manager
About the Company
Mydecine is a biotechnology company developing first- and second-generation novel compounds to treat mental health and addiction disorders through world-class technology and drug development infrastructure. The company's medical and scientific advisory board is progressing a robust research and development (R&D) pipeline of
psychedelic-derived therapeutics, novel compounds, therapies, and controlled drug delivery systems.
